Sfoglia per RIVISTA
EUROPEAN JOURNAL OF CANCER (OXFORD, ENGLAND : 1990)
Collezione AO Ordine Mauriziano

  

Items : 16

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.

2024
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Salerno F; Silva RR; Baldini E; Cortellini A; Brighenti M; Santoni M; Malorgio F; Caminiti C; Tiseo M; Camerini A; Carta A; Follador A; Zoratto F; Cortinovis DL; Berardi R; Toschi L; Citarella F; Bulotta A; Rastelli F; Adamo V; Manzo A; Cecere FL; Guida A; Belluomini L; Roca E; Pasello G; Montrone M; Cerea G; Delcuratolo MD; et alii...

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;203:114039. doi: 10.1016/j.ejca.2024.114039. Epub 2024 Mar 30.

2024
AO Ordine Mauriziano

Tuninetti V; Virano E; Salutari V; Ricotti A; Pisano C; Ducceschi M; Turitto G; Scandurra G; Petrella MC; Forestieri V; Rizzetto M; Mammoliti S; Artioli G; Pignata S; Valabrega G; Azzolina C; Geninatti E; Mantiero M; Ferrandina G; Carbone V; Rognone C; Borsotti L; Bellero M; Cioffi R;

Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Feb;180:117-124. doi: 10.1016/j.ejca.2022.12.005. Epub 2022 Dec 12.

2023
AO Ordine Mauriziano

Besse B; Hochstenbag M; Hendriks LEL; Marcuse F; Tiseo M; Remon J; Facchinetti F; Di Maio M; Villacampa G;

Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Dec;195:113374. doi: 10.1016/j.ejca.2023.113374. Epub 2023 Oct 22.

2023
AO Ordine Mauriziano

Di Maio M; Perrone F; Marandino L; Paparo J; Notarnicola S; Zumstein L;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
AO Cuneo
ASL Cuneo 2
AO Ordine Mauriziano
ASL Torino 4
AOU San Luigi di Orbassano

Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M; Reale ML; Trastu F; Paratore C; Marandino L; Mariniello A; Lombardi P; Ghisoni E; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Rossi A; Aimar G; Audisio M;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Righi L; Novello S; Graziano P; Scagliotti GV; Bria E; Volante M; Rossi A; Rossi G; Osman G; Di Maio M; Bareggi C; Del Conte A; Cappuzzo F; Cortinovis D; Pilotto S; Gregorc V; Sergi C; Ghilardi L; Scotti V; Martelli O; Tiseo M; Galetta D; Maiello E; Rigutto A; Castellana S; Trombetta D; Gobbini E; Tabbò F; Muscarella LA; et alii...

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:153-164. doi: 10.1016/j.ejca.2021.03.010. Epub 2021 Apr 14.

2021
AO Ordine Mauriziano

Peters S; Coukos G; Zimmermann S; Mederos Alfonso NN; Homicsko K; Obeid M; Aglietta M; Valabrega G; Marandino L; Tavazzi E; Gatta R; Pradervand S; Özdemir BC; Caikovski M; Latifyan S; Gautron Moura B; Gérard CL; Imbimbo M; Delyon J; Bouchaab H; Ghisoni E; Wicky A; Cuendet MA; Di Maio M; Michielin O;

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Dei Tos AP; Lonardi S; Zagonel V; Borga C; Biason P; Centonze G; Santini D; Salmaso R; Aprile G; Salvatore L; Calvetti L; Smiroldo V; Rimassa L; De Maglio G; Cortiula F; Morano F; Volante M; Boccaccino A; Bergamo F; Zichi C; Sperti E; Dell'Aquila E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; Milione M; Fassan M; et alii...

D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:10-22. doi: 10.1016/j.ejca.2021.03.031. Epub 2021 Apr 19.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino
AOU Città della Salute di Torino
ASL Torino 3

Morino M; Ponti A; Sasako M; Degiuli M; Reddavid R; Tomatis M;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino

Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M;

Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Jun;78:122-132. doi: 10.1016/j.ejca.2017.03.025. Epub 2017 Apr 24.

2017
AO Ordine Mauriziano

Aliberti S; Aglietta M; Dei Tos AP; Pisacane A; De Simone M; Ferrero A; Siatis D; Pignochino Y; Sangiolo D; Venesio T; Campanella D; Russo F; Bertotto I; Chiara G; Manca A; Galizia D; Miano S; Tolomeo F; Boccone P; D'Ambrosio L; Palesandro E; Grignani G;

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2015 Feb;51(3):352-8. doi: 10.1016/j.ejca.2014.11.017. Epub 2014 Dec 17.

2015
AO Ordine Mauriziano

Mahner S; Meier W; du Bois A; Brown C; Lorusso D; Dell'Anna T; Cretin J; Havsteen H; Bessette P; Zeimet AG; Vergote I; Vasey P; Pujade-Lauraine E; Gladieff L; Ferrero A;